Emphysema Market is segmented By Treatment (Bronchodilators, Corticosteroids, Antibiotics, Vaccines, Supplemental Oxygen Therapy), By Distribution Channel (Hospital Pharm ....
Market Size in USD
CAGR3.8%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 3.8% |
Market Concentration | Medium |
Major Players | Boehringer Ingelheim GmbH, AstraZeneca plc, GlaxoSmithKline plc, Novartis International AG, F. Hoffmann-La Roche Ltd |
The emphysema market is estimated to be valued at USD 5.15 Bn in 2024 and is expected to reach USD 6.7 Bn by 2031, growing at a compound annual growth rate (CAGR) of 3.8% from 2024 to 2031. The majority of the market is concentrated in North America and Europe due to higher disease prevalence and access to advanced healthcare facilities in these regions.